129 results on '"Ashish H. Shah"'
Search Results
2. Brain Metastasis from Pancreatic Cancer: Our Experience and Systematic Review
- Author
-
Frank A. De Stefano, Alexis Morell, Katya Marks, Sophia Fernandez, Grace Smith, Timothy Mayo, Martin Merenzon, Ashish H. Shah, Daniel G. Eichberg, Evan Luther, Michael E. Ivan, and Ricardo J. Komotar
- Subjects
Pancreatic Neoplasms ,Brain Neoplasms ,Humans ,Surgery ,Neurology (clinical) ,Prognosis ,Retrospective Studies - Abstract
To systematically review existing literature on the neurosurgical management and outcomes of brain metastasis from pancreatic cancer in comparison with our institutional experience of this patient cohort.Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic literature review was performed using PubMed, Ovid Embase, Scopus, and Web of Science databases from date of database inception to March 2022. Studies were selected based on predetermined inclusion and exclusion criteria. Simultaneously, a retrospective analysis was conducted of patients who underwent neurosurgical evaluation and treatment for intracranial metastatic lesions from pancreatic origin at a single institution.The original literature search yielded 292 articles, of which 17 studies comprising 23 patients with brain metastases of pancreatic origin were ultimately selected. Median overall survival from primary diagnosis of pancreatic cancer was 22 months (interquartile range: 3-84) and 3 months (interquartile range: 1-36) after diagnosis of brain metastasis. In our institutional cohort, 4 patients were identified with a median overall survival of 30.5 months (interquartile range: 2-108). Our institutional cohort experienced a prolonged median overall survival (3 months vs. 30.5 months, P = 0.03) compared with the literature.Brain metastasis from pancreatic cancer is rare and associated with a fatal outcome. However, based on the data presented in this review, patient-specific and treatment-related factors could signal better prognosis. Further studies are needed to elucidate multimodal therapy and survival to suggest a more personalized decision-making process.
- Published
- 2022
- Full Text
- View/download PDF
3. Traumatic brain injury and subsequent brain tumor development: a systematic review of the literature
- Author
-
Darsh S. Shah, Akshat Sanan, Alexis A. Morell, Daniel G. Eichberg, Ashish H. Shah, Evan Luther, Victor M. Lu, Turki Elarjani, Dominic M. O. Higgins, Nitesh V. Patel, Jonathan R. Jagid, Michael E. Ivan, and Ricardo J. Komotar
- Subjects
Surgery ,Neurology (clinical) ,General Medicine - Published
- 2022
- Full Text
- View/download PDF
4. Trends in Leadership Among Neurosurgical Oncology Fellowships
- Author
-
David P. Matichak, Adam S. Levy, Nathan Vanderveer-Harris, Henry Chang, Frederic Vallejo, Benjamin Schachner, Ashish H. Shah, Ricardo J. Komotar, Vikram Chakravarthy, and Michael E. Ivan
- Subjects
Surgery ,Neurology (clinical) - Published
- 2023
- Full Text
- View/download PDF
5. Predicting Academic Career Placement via Development of Novel Intra-residency Metrics
- Author
-
Vaidya Govindarajan, Ashish H. Shah, Alexis A. Morell, Veronica Borowy, Shreya M. Ingle, Mynor J. Mendez Valdez, Sarah Rivas, Daniel G. Eichberg, Evan Luther, Victor Lu, John Heiss, Ricardo J. Komotar, and Allan D. Levi
- Subjects
Surgery ,Neurology (clinical) - Published
- 2023
- Full Text
- View/download PDF
6. Surgical Approaches to Thalamic Gliomas: A Systematic Review
- Author
-
Martín Merenzon, Adam S. Levy, Shovan Bhatia, Tiffany Eatz, Alexis A. Morell, Lekhaj Daggubati, Katherine Berry, Daniel G. Eichberg, Jay Chandar, Ashish H. Shah, Evan Luther, Victor M. Lu, Ricardo J. Komotar, and Michael E. Ivan
- Subjects
Surgery ,Neurology (clinical) - Abstract
Adult thalamic gliomas (ATGs) present a surgical challenge given their depth and proximity to eloquent brain regions. Choosing a surgical approach relies on different clinical variables such as anatomical location and size of the tumor. However, conclusive data regarding how these variables influence the balance between extent of resection and complications are lacking. We aim to systematically review the literature to describe the current surgical outcomes of ATG and to provide tools that may improve the decision-making process.Literature regarding the surgical management of ATG patients was reviewed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Four databases were queried and a description of clinical characteristics and survival analysis were performed. An individual patient data analysis was conducted when feasible.A total of 462 patients were included from 13 studies. The mean age was 39.8 years with a median preoperative Karnofsky performance scale of 70. The lateral approaches were most frequently used (74.9%), followed by the interhemispheric (24.2%). Gross total and subtotal/partial resections were achieved in 81%, and 19% of all cases, respectively. New permanent neurological deficits were observed in 51/433 patients (11.8%). individual patient data was pooled from 5 studies (n = 71). In the multivariate analysis, tumors located within the posterior thalamus had worse median overall survival compared to anterior gliomas (14.5 vs. 27 months, P = 0.003).Surgical resection of ATGs can increase survival but at the risk of operative morbidity. Knowing which factors impact survival may allow neurosurgeons to propose a more evidence-based treatment to their patients.
- Published
- 2022
7. Is endoscopic resection a useful technique for a cavernous sinus sellar cavernoma? A case report and literature review
- Author
-
Evan Luther, Ricardo J. Komotar, Victor M. Lu, Franco Rubino, Ali G Saad, Ashish H. Shah, Daniel G Eichberg, and Michael E. Ivan
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Vascular malformation ,Subtotal Resection ,General Medicine ,Cavernous malformations ,medicine.disease ,Radiation therapy ,Cavernous sinus ,otorhinolaryngologic diseases ,Medicine ,Surgery ,Endoscopic resection ,Neurology (clinical) ,Radiology ,business - Abstract
Cavernous sinus cavernous malformations (CSCMs) is a vascular malformation of the cavernous sinus. Nowadays, there is an increasing preference to withhold using the terms cavernoma or cavernous hemangioma in order to stop considering these lesions as vascular neoplasms. These lesions are highly vascularized making surgical resection a challenge, mainly in endoscopic approaches. We present a case of this tumor treated in our institution with an endoscopic endonasal approach and incomplete resection. Because of the strenuous resection through this approach, we systematically reviewed the reported endoscopic cases of CSCMs to determine their intraoperative complications, results and tumor features.Using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, one database (PubMed) and crossed references were queried for CSCMs from 1948 to 2020. Data regarding demographic features, clinical presentation, MRI features, surgical results and overall pathology features extracted.Eighteen patients were selected (including our case). The mean age was 50.4 ± 14 years. Pituitary dysfunction and cavernous sinus nerve compression were the most reported symptoms. Only five cases (27%) reported a gross total resection (GTR) through endoscopic endonasal approach. Intraoperative bleeding was the most frequent intraoperative complication.We present a comprehensive analysis of every reported CSCM treated through endoscopic approach. Partial or subtotal resection are the most used techniques because of the intraoperative bleeding and the adherence to surrounding structures. Radiotherapy is a very good option for patients with incomplete resections.
- Published
- 2021
- Full Text
- View/download PDF
8. Robotic guidance platform for laser interstitial thermal ablation and stereotactic needle biopsies: a single center experience
- Author
-
Michael E. Ivan, Long Di, Daniel G Eichberg, Evan Luther, Victor M. Lu, Karen Eliahu, Franco Rubino, Ashish H. Shah, Ricardo J. Komotar, and Joacir Graciolli Cordeiro
- Subjects
medicine.medical_specialty ,Thermal ablation ,Health Informatics ,Stereotactic procedures ,Single Center ,Brain tumors ,Laser Interstitial Thermal Therapy ,Robotic Surgical Procedures ,medicine ,Skull bone ,Humans ,Stereotactic neurosurgery ,Aged ,Retrospective Studies ,business.industry ,Lasers ,Biopsy, Needle ,Robotic neurosurgery ,Robotics ,Middle Aged ,Magnetic Resonance Imaging ,Catheter ,ROSA robot ,LITT ,Surgery ,Original Article ,Radiology ,Laser Therapy ,Catheter placement ,Fiducial marker ,business - Abstract
While laser ablation has become an increasingly important tool in the neurosurgical oncologist’s armamentarium, deep seated lesions, and those located near critical structures require utmost accuracy during stereotactic laser catheter placement. Robotic devices have evolved significantly over the past two decades becoming an accurate and safe tool for stereotactic neurosurgery. Here, we present our single center experience with the MedTech ROSA ONE Brain robot for robotic guidance in laser interstitial thermal therapy (LITT) and stereotactic biopsies. We retrospectively analyzed the first 70 consecutive patients treated with ROSA device at a single academic medical center. Forty-three patients received needle biopsy immediately followed by LITT with the catheter placed with robotic guidance and 27 received stereotactic needle biopsy alone. All the procedures were performed frameless with skull bone fiducials for registration. We report data regarding intraoperative details, mortality and morbidity, diagnostic yield and lesion characteristics on MRI. Also, we describe the surgical workflow for both procedures. The mean age was 60.3 ± 15 years. The diagnostic yield was positive in 98.5% (n = 69). Sixty-three biopsies (90%) were supratentorial and seven (10%) were infratentorial. Gliomas represented 54.3% of the patients (n = 38). There were two postoperative deaths (2.8%). No permanent morbidity related to surgery were observed. We did not find intraoperative technical problems with the device. There was no need to reposition the needle after the initial placement. Stereotactic robotic guided placement of laser ablation catheters and biopsy needles is safe, accurate, and can be implemented into a neurosurgical workflow.
- Published
- 2021
9. Safety and Facial Nerve Outcomes of Intracisternal Papaverine Irrigation for Vestibular Schwannoma Resection
- Author
-
Michael A. Silva, Henry Chang, Ashish H. Shah, Nickalus R. Khan, Clifford S. Brown, Christine T. Dinh, Adrien A. Eshraghi, Fred F. Telischi, Simon I. Angeli, and Jacques J. Morcos
- Subjects
Surgery ,Neurology (clinical) - Abstract
Papaverine, a vasodilator approved for use by the U.S. Food and Drug Administration, has shown efficacy in treating vasospasm in cardiology, urology, and nephrology. The vasodilatory effect of papaverine is also hoped to protect the facial nerve from ischemic damage and nerve manipulation during vestibular schwannoma surgery. Our institution uses intracisternal papaverine irrigation during vestibular schwannoma resection to protect the facial nerve in patients with neuromonitoring changes. Our objective was to investigate the safety and facial nerve outcomes of intracisternal papaverine irrigation during vestibular schwannoma resection.We retrospectively reviewed patients who underwent resection of vestibular schwannoma at our institution between 2008 and 2021. Patients received papaverine if the intraoperative facial nerve stimulation threshold increased above 0.05 mA. Postoperative outcomes were compared with control patients who did not receive papaverine.A total of 283 cases were included in our analysis. Patients who received papaverine (n = 60) had lower immediate postoperative House-Brackmann (HB) grades than did control individuals (mean, 1.54 vs. 1.95; P = 0.029) and a lower likelihood of immediate postoperative HB grade1 (odds ratio, 0.514; P = 0.039). At long-term follow-up, there was no significant difference in HB grade. Papaverine use was not associated with increased rates of perioperative complications (P = 0.24).The off-label use of intracisternal papaverine irrigation during vestibular schwannoma resection can certainly be used safely for select cases. It is associated with improved immediate postoperative facial nerve outcomes, similar long-term facial nerve outcomes, and no significant increase in complications.
- Published
- 2022
10. Stimulated Raman Histology for Rapid Intraoperative Diagnosis of Gliomas
- Author
-
Ashish H. Shah, Evan Luther, Ricardo J. Komotar, Victor M. Lu, Michael E. Ivan, Sakir H. Gultekin, Aria M. Jamshidi, Kevin Huang, Long Di, and Daniel G Eichberg
- Subjects
Adult ,Male ,medicine.medical_specialty ,Brain tumor ,Sensitivity and Specificity ,Neurosurgical Procedures ,Intraoperative Period ,03 medical and health sciences ,0302 clinical medicine ,Glioma ,Image Processing, Computer-Assisted ,medicine ,Humans ,Computer Simulation ,Prospective Studies ,Prospective cohort study ,Aged ,Permanent Section ,Aged, 80 and over ,Frozen section procedure ,Brain Neoplasms ,business.industry ,Margins of Excision ,Reproducibility of Results ,Histology ,Gold standard (test) ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,030220 oncology & carcinogenesis ,Female ,Surgery ,Histopathology ,Neurology (clinical) ,Radiology ,business ,030217 neurology & neurosurgery - Abstract
Intraoperative pathologic diagnosis traditionally involves frozen section histopathology, which may be labor and time intensive. Indeed, a technique that streamlines the acquisition and evaluation of intraoperative histologic data may expedite surgical decision-making and shorten operative time. Stimulated Raman histology (SRH) is an emerging technology that allows for more rapid acquisition and interpretation of intraoperative histopathologic data.A blinded, prospective cohort study was performed for 82 patients undergoing resection for a central nervous system tumor. Of these, 21 patients were diagnosed with glioma either intraoperatively or postoperatively on permanent section histology and included in this study. Time to diagnosis (TTD) and diagnostic accuracy relative to permanent section (the gold standard) were compared between SRH-based diagnosis and conventional frozen section histology. Diagnostic concordance with permanent section was also compared between frozen histopathology and SRH diagnosis.Diagnostic accuracy was not significantly different between methods (P = 1.00). Diagnostic concordance was not significantly different between methods when comparing 95% confidence intervals for kappa values (κ = 0.215; κ = 0.297; κ = 0.369). Lastly, mean TTD was significantly shorter with SRH-based diagnosis compared with frozen section (43 vs. 9.7 minutes, P0.0001). SRH was able to identify key features associated with varying glioma types.SRH allows for rapid intraoperative diagnosis without sacrificing diagnostic accuracy. SRH may serve as a promising adjuvant to conventional histopathology to expedite intraoperative pathology consultation and surgical decision-making.
- Published
- 2021
- Full Text
- View/download PDF
11. Neuro-oncology practice guidelines from a high-volume surgeon at the COVID-19 epicenter
- Author
-
Michael E. Ivan, Gregory W. Basil, Evan Luther, Ricardo J. Komotar, Victor M. Lu, Katherine Berry, Ashish H. Shah, Joshua D. Burks, Daniel G Eichberg, and Gurvinder Kaur
- Subjects
medicine.medical_specialty ,Telemedicine ,Coronavirus disease 2019 (COVID-19) ,Neuro oncology ,Clinical Neurology ,Neurosurgery ,Telehealth ,Neurosurgical Procedures ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,law ,Physiology (medical) ,Neuro-oncology ,Quarantine ,Pandemic ,medicine ,Humans ,Pandemics ,Oncologists ,Surgeons ,Brain Neoplasms ,business.industry ,COVID-19 ,Patient Preference ,General Medicine ,Coronavirus ,Outpatient visits ,Neurology ,030220 oncology & carcinogenesis ,Communicable Disease Control ,Emergency medicine ,Clinical Study ,Surgery ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
Background During the coronavirus 19 (COVID-19) pandemic, physicians have begun adapting their daily practices to prevent transmissions. In this study we aimed to provide surgical neuro-oncologists with practice guidelines during the COVID-19 pandemic based on objective data from a high-volume brain tumor surgeon at the current COVID-19 epicenter. Methods All outpatient visits and surgeries performed by the senior author during the COVID-19 pandemic were compared between the initial quarantine (3/23/20–5/4/20), the plateau period following quarantine (5/5/20–6/27/20), and the second peak (6/28/20–7/20/20). In-person and telemedicine visits were evaluated for crossovers. Surgeries were subdivided based on lesion type and evaluated across the same time period. Results From 3/23/20–7/20/20, 469 clinic visits and 196 surgeries were identified. After quarantine was lifted, face-to-face visits increased (P
- Published
- 2021
- Full Text
- View/download PDF
12. Rare Tumor-to-Tumor Metastases Involving Lung Adenocarcinoma to Petroclival Meningiomas
- Author
-
Ashish H. Shah, Sakir H. Gultekin, Stephanie H Chen, David J McCarthy, Alejandro Matus, Evan Luther, Nikolas Echeverry, Daniel G Eichberg, Jacques J. Morcos, Michael E. Ivan, and Samuel Mansour
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Brain tumor ,medicine.disease ,Meningioma ,03 medical and health sciences ,0302 clinical medicine ,Skull Base Meningioma ,030220 oncology & carcinogenesis ,medicine ,Adenocarcinoma ,Surgery ,Neurology (clinical) ,Radiology ,Differential diagnosis ,Petroclival Meningioma ,business ,030217 neurology & neurosurgery ,Craniotomy ,Petroclival Region - Abstract
Background Lung carcinoma metastasizing to a skull base meningioma remains an extremely rare phenomenon, with only 3 studies reported. Furthermore, no documented cases have been reported in the petroclival region. Thus, we have presented the first 2 cases of tumor-to-tumor metastasis (TTM) in which a petroclival lesion, initially thought to be purely meningioma, was also found to contain metastatic lung adenocarcinoma. Case Description We present the cases of 2 patients with a known history of lung adenocarcinoma and stable petroclival meningioma who had presented with new-onset neurologic deficits. Repeat imaging studies for both patients found an increased lesion size and peritumoral enhancement; thus, both patients underwent emergent craniotomy for complete lesion resection. Intraoperatively, both lesions had zones of markedly different tumoral texture. On histologic analysis, both lesions showed metastatic lung adenocarcinoma contained within the primary petroclival meningioma. Conclusion Skull base TTM is a rare entity for which no specific management guidelines have been created. Therefore, even if the imaging characteristics suggest a more benign process, skull base TTM should remain high on the differential diagnosis for patients with a known primary cancer and new-onset, rapidly progressive, neurologic deficits. Close clinical follow-up with short-interval repeat imaging in this subset of patients might prevent misdiagnosis and facilitate prompt treatment.
- Published
- 2020
- Full Text
- View/download PDF
13. Complete Regression of a Solitary Cholangiocarcinoma Brain Metastasis Following Laser Interstitial Thermal Therapy
- Author
-
Sakir H. Gultekin, Sze Kiat Tan, Daniel G Eichberg, Evan Luther, Ricardo J. Komotar, Aria M. Jamshidi, Khadeja Khan, Michael E. Ivan, and Ashish H. Shah
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Magnetic resonance imaging ,medicine.disease ,Metastasis ,Lesion ,03 medical and health sciences ,0302 clinical medicine ,Laser Interstitial Thermal Therapy ,030220 oncology & carcinogenesis ,Edema ,medicine ,Enhancing Lesion ,Surgery ,Neurology (clinical) ,Radiology ,medicine.symptom ,business ,030217 neurology & neurosurgery ,Intrahepatic Cholangiocarcinoma ,Brain metastasis - Abstract
Background To our knowledge, we report the first case of a cholangiocarcinoma brain metastasis successfully treated with magnetic resonance imaging (MRI)-guided laser interstitial thermal therapy. Case Description In 2017, a 71-year-old man was diagnosed with unresectable intrahepatic cholangiocarcinoma. In August 2018, a brain MRI scan was performed after a transient episode of altered mental status and revealed a subcentimeter enhancing lesion in the deep white matter of the right cerebellum. Due to lack of symptoms and the small size of the lesion, it was initially observed. However, a follow-up MRI scan at 2.5 months demonstrated increased lesion size with worsening perilesional edema. Given the rarity of cholangiocarcinoma brain metastases and the deep location, the patient underwent stereotactic needle biopsy to confirm the diagnosis followed by laser ablation as a primary treatment for the metastasis. The patient tolerated the surgery well with no complications, and the postoperative course was uneventful. At 16 months postablation, there has been no recurrence or disease progression. Conclusions Although prognosis for these tumors is poor, our result suggests that laser ablation can be an effective treatment for this rare entity and is a representative example of the expanding indications for laser interstitial thermal therapy.
- Published
- 2020
- Full Text
- View/download PDF
14. Long-term outcomes after surgery for catastrophic epilepsy in infants: institutional experience and review of the literature
- Author
-
Shelly Wang, Sanjiv Bhatia, Justin K. Achua, George M. Ibrahim, Ashish H. Shah, Samir Sur, Vincent C. Ye, and John Ragheb
- Subjects
medicine.medical_specialty ,Seizure frequency ,Hemimegalencephaly ,business.industry ,medicine.medical_treatment ,Psychological intervention ,General Medicine ,Cortical dysplasia ,medicine.disease ,Surgery ,Hemispherectomy ,03 medical and health sciences ,Epilepsy ,0302 clinical medicine ,Catastrophic epilepsy ,030220 oncology & carcinogenesis ,medicine ,Long term outcomes ,business ,030217 neurology & neurosurgery - Abstract
OBJECTIVEUncontrolled epilepsy is associated with serious deleterious effects on the neurological development of infants and has been described as “catastrophic epilepsy.” Recently, there has been increased emphasis on early surgical interventions to preserve or rescue neurodevelopmental outcomes in infants with early intractable epilepsy. The enthusiasm for early treatments is often tempered by concerns regarding the morbidity of neurosurgical procedures in very young patients. Here, the authors report outcomes following the surgical management of infants (younger than 1 year).METHODSThe authors performed a retrospective review of patients younger than 1 year of age who underwent surgery for epilepsy at Miami (Nicklaus) Children’s Hospital and Jackson Memorial Hospital between 1994 and 2018. Patient demographics, including the type of interventions, were recorded. Seizure outcomes (at last follow-up and at 1 year postoperatively) as well as complications are reported.RESULTSThirty-eight infants (median age 5.9 months) underwent a spectrum of surgical interventions, including hemispherectomy (n = 17), focal resection (n = 13), and multilobe resections (n = 8), with a mean follow-up duration of 9.1 years. Hemimegalencephaly and cortical dysplasia were the most commonly encountered pathologies. Surgery for catastrophic epilepsy resulted in complete resolution of seizures in 68% (n = 26) of patients, and 76% (n = 29) had a greater than 90% reduction in seizure frequency. Overall mortality and morbidity were 0% and 10%, respectively. The latter included infections (n = 2), infarct (n = 1), and immediate reoperation for seizures (n = 1).CONCLUSIONSSurgical intervention for catastrophic epilepsy in infants remains safe, efficacious, and durable. The authors’ work provides the longest follow-up of such a series on infants to date and compares favorably with previously published series.
- Published
- 2020
- Full Text
- View/download PDF
15. Central Neurocytoma Treatment Modalities: A Systematic Review Assessing the Outcomes of Combined Maximal Safe Resection and Radiotherapy with Gross Total Resection
- Author
-
Michael E. Ivan, Evan Luther, Ricardo J Komotar, Anil K. Mahavadi, Ashish H. Shah, Priyen M. Patel, Daniel G Eichberg, and Manish Kuchakulla
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Extent of resection ,Neurosurgical Procedures ,Resection ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,medicine ,Central neurocytoma ,Humans ,Neurocytoma ,Brain Neoplasms ,business.industry ,medicine.disease ,Combined Modality Therapy ,Gross Total Resection ,Surgery ,Radiation therapy ,Treatment Outcome ,Treatment modality ,030220 oncology & carcinogenesis ,Radiotherapy, Adjuvant ,Neurology (clinical) ,Neoplasm Recurrence, Local ,Complication ,business ,Adjuvant ,030217 neurology & neurosurgery - Abstract
Background Central neurocytomas (CNCs) are rare intraventricular lesions comprising Objective Our goal was to update Rades et al.‘s 2006 systematic review to assess the outcome differences among 3 fundamental therapies for CNC: gross total resection with and without radiation therapy (RT) versus maximal safe resection with adjuvant RT. Methods Articles indexed on PubMed and Google Scholar and published between January 1, 2006 and December 31, 2019 were selected using the PRISMA criteria. Studies were excluded if they had fewer than 3 cases, did not categorize extent of resection, or were duplicate studies, technical reports, case reports, or studies without follow-up. Complication rates, recurrence rates, overall survival and progression-free survival were extracted where possible. χ2 proportionality tests were used for comparison (P values >0.05 suggested significance). Results On aggregation, 615 patients from 13 studies including ours were assessed. Although overall survival was not significantly different (χ2 = 1.56; P = 0.46), the recurrence rate differed significantly between GTR + RT (6.9%, 92.11 months), GTR–RT (23.9%, 96.8 months), and MSR + RT (16.8%, 85 months) (χ2 = 10.94; P = 0.004). Pooled complication rates for GTR and MSR + RT were 31.2% and 24% (P = 0.049), respectively. Conclusions RT remains an important adjuvant treatment that can improve patient survival in the presence of MSR to levels comparable to those of GTR or GTR + RT. Where total resection carries too much risk, MSR + RT can be considered as the next best alternative for tumor control.
- Published
- 2020
- Full Text
- View/download PDF
16. Endoscopic third ventriculostomy with choroid plexus cauterization for the treatment of infantile hydrocephalus in Haiti
- Author
-
Iahn Cajigas, John Ragheb, Ariel Henry, Ernest J. Barthélemy, George M. Ibrahim, Stephanie H Chen, Ashish H. Shah, Yudy Lafortune, and Michael Ragheb
- Subjects
Ventriculostomy ,medicine.medical_specialty ,Univariate analysis ,Multivariate analysis ,business.industry ,medicine.medical_treatment ,Endoscopic third ventriculostomy ,General Medicine ,Infantile hydrocephalus ,medicine.disease ,Surgery ,Hydrocephalus ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,medicine ,Cauterization ,Choroid plexus ,business ,030217 neurology & neurosurgery - Abstract
OBJECTIVEUntreated hydrocephalus poses a significant health risk to children in the developing world. In response to this risk, global neurosurgical efforts have increasingly focused on endoscopic third ventriculostomy with choroid plexus cauterization (ETV/CPC) in the management of infantile hydrocephalus in low- and middle-income countries (LMICs). Here, the authors report their experience with ETV/CPC at the Hospital Bernard-Mevs/Project Medishare (HBMPM) in Port-au-Prince, Haiti.METHODSThe authors conducted a retrospective review of a series of consecutive children who had undergone ETV/CPC for hydrocephalus over a 1-year period at HBMPM. The primary outcome of interest was time to ETV/CPC failure. Univariate and multivariate analyses using a Cox proportional hazards regression were performed to identify preoperative factors that were associated with outcomes.RESULTSOf the 82 children who underwent ETV/CPC, 52.2% remained shunt free at the last follow-up (mean 6.4 months). On univariate analysis, the ETV success score (ETVSS; p = 0.002), success of the attempted ETV (p = 0.018), and bilateral CPC (p = 0.045) were associated with shunt freedom. In the multivariate models, a lower ETVSS was independently associated with a poor outcome (HR 0.072, 95% CI 0.016–0.32, p < 0.001). Two children (2.4%) died of postoperative seizures.CONCLUSIONSAs in other LMICs, ETV/CPC is an effective treatment for hydrocephalus in children in Haiti, with a low but significant risk profile. Larger multinational prospective databases may further elucidate the ideal candidate for ETV/CPC in resource-poor settings.
- Published
- 2020
- Full Text
- View/download PDF
17. Hair-sparing technique using absorbable intradermal barbed suture versus traditional closure methods in supratentorial craniotomies for tumor
- Author
-
Evan Luther, Simon Buttrick, Daniel G Eichberg, Michael E. Ivan, Ashish H. Shah, Katherine Berry, David J McCarthy, Ricardo J. Komotar, Jagteshwar Sandhu, Angela M. Richardson, Christina Guerrero, and Roxanne Mayrand
- Subjects
medicine.medical_specialty ,integumentary system ,medicine.diagnostic_test ,Wound dehiscence ,business.industry ,medicine.medical_treatment ,Interventional radiology ,Perioperative ,medicine.disease ,030218 nuclear medicine & medical imaging ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Barbed suture ,Scalp ,medicine ,sense organs ,Neurology (clinical) ,Neurosurgery ,Complication ,business ,030217 neurology & neurosurgery ,Craniotomy - Abstract
Hair-sparing techniques in cranial neurosurgery have gained traction in recent years and previous studies have shown no difference in infection rates, yet limited data exists evaluating the specific closure techniques utilized during hair-sparing craniotomies. Therefore, it was the intention of this study to evaluate the rate of surgical site infections (SSIs) and perioperative complications associated with using an absorbable intradermal barbed suture for skin closure in hair-sparing supratentorial craniotomies for tumor in order to prove non-inferiority to traditional methods. A retrospective review of supratentorial craniotomies for tumor by a single surgeon from 2011 to 2017 was performed. All perioperative adverse events and wound complications, defined as a postoperative infection, wound dehiscence, or CSF leak, were compared between three different groups: (1) hair shaving craniotomies + transdermal polypropylene suture/staples for scalp closure, (2) hair-sparing craniotomies + transdermal polypropylene suture/staples for scalp closure, and (3) hair-sparing craniotomies + absorbable intradermal barbed suture for scalp closure. Two hundred sixty-three patients underwent hair shaving + transdermal polypropylene suture/staples, 83 underwent hair sparing + transdermal polypropylene suture/staples, and 100 underwent hair sparing + absorbable intradermal barbed suture. Overall, 2.9% of patients experienced a perioperative complication and 4.3% developed a wound complication. In multivariable analysis, the use of a barbed suture for scalp closure and hair-sparing techniques was not predictive of any complication or 30-day readmission. Furthermore, the absorbable intradermal barbed suture cohort had the lowest overall rate of wound complications (4%). Hair-sparing techniques using absorbable intradermal barbed suture for scalp closure are safe and do not result in higher rates of infection, readmission, or reoperation when compared with traditional methods.
- Published
- 2020
- Full Text
- View/download PDF
18. Systematic Review of Epigenetic Therapies for Treatment of IDH-mutant Glioma
- Author
-
Vaidya Govindarajan, Ashish H. Shah, Long Di, Sarah Rivas, Robert K. Suter, Daniel G. Eichberg, Evan Luther, Victor Lu, Alexis A. Morell, Michael E. Ivan, Ricardo J. Komotar, Nagi Ayad, and Macarena De La Fuente
- Subjects
Histone Deacetylase Inhibitors ,Brain Neoplasms ,Mutation ,Humans ,Surgery ,Neurology (clinical) ,Glioma ,Article ,Isocitrate Dehydrogenase ,Epigenesis, Genetic - Abstract
BACKGROUND: Isocitrate dehydrogenase (IDH) mutations are present in 70% of World Health Organization grade II and III gliomas. IDH mutation induces accumulation of the oncometabolite 2-hydroxyglutarate. Therefore, therapies targeting reversal of epigenetic dysregulation in gliomas have been suggested. However, the utility of epigenetic treatments in gliomas remains unclear. Here, we present the first clinical systematic review of epigenetic therapies in treatment of IDH-mutant gliomas and highlight their safety and efficacy. METHODS: We conducted a systematic search of electronic databases from 2000 to January 2021 following PRISMA guidelines. Articles were screened to include clinical usage of epigenetic therapies in case reports, prospective case series, or clinical trials. Primary and secondary outcomes included safety/tolerability of epigenetic therapies and progression-free survival/overall survival, respectively. RESULTS: A total of 133 patients across 8 clinical studies were included in our analysis. IDH inhibitors appear to have the best safety profile, with an overall grade 3/grade 4 adverse event rate of 9%. Response rates to IDH-mutant inhibitors were highest in nonenhancing gliomas (stable disease achieved in 55% of patients). In contrast, histone deacetylase inhibitors demonstrate a lower safety profile with single-study adverse events as high as 28%. CONCLUSION: IDH inhibitors appear promising given their benign toxicity profile and ease of monitoring. Histone deacetylase inhibitors appear to have a narrow therapeutic index, as lower concentrations do not appear effective, while increased doses can produce severe immunosuppressive effects. Preliminary data suggest that epigenetic therapies are generally well tolerated and may control disease in certain patient groups, such as those with nonenhancing lesions.
- Published
- 2022
19. Contemporary outcomes of diffuse leptomeningeal glioneuronal tumor in pediatric patients: A case series and literature review
- Author
-
Victor M. Lu, Long Di, Joanna Gernsback, Daniel G. Eichberg, Evan M. Luther, Ashish H. Shah, David J. Daniels, Ossama M. Maher, and Toba N. Niazi
- Subjects
Central Nervous System ,Male ,Adolescent ,Research ,General Medicine ,Neoplasms, Neuroepithelial ,Central Nervous System Neoplasms ,Child, Preschool ,Meningeal Neoplasms ,Humans ,Surgery ,Female ,Neurology (clinical) ,Child - Abstract
Diffuse leptomeningeal glioneuronal tumor (DLGNT), also known as oligodendrogliomatosis, is a rare neuro-oncologic condition along the neuraxis that remains poorly understood in children. We sought to describe our institutional experience and quantitively summarize the clinical survival and prognostic features of DLGNT in the pediatric population across the contemporary literature.We report four institutional cases of pediatric DLGNT diagnosed between 2000 and 2020 based on retrospective review of our records, and performed a comprehensive literature search for published cases from 2000 onwards to create an integrated cohort for analysis. Kaplan-Meier estimations, Fisher's exact test, and logistic regression were utilized to interrogate the data.Of our four cases, three females aged 2-, 3- and 13-years old at diagnosis survived 6-years, 3-years and 14-months respectively, and one male aged 5-years old at diagnosis was still alive 5 years later. Our overall integrated cohort consisted of 54 pediatric DLGNT patients, with 19 (35%) female and 35 (65%) male patients diagnosed at an average age of 6.4 years (range, 1.3-17 years) by means of surgical biopsy. Chemotherapy was used in 45 cases (83%), and mean follow-up time of 54 months (range, 3-204). Across the entire cohort, overall survival 1 month after diagnosis was 96% (95% CI 86-99%), and by 10 years was 69% (95% CI 49-82%). On multivariate analysis of complete data, chemotherapy treatment (HR=0.23, P = 0.04) was statistically predictive of longer overall survival.More than 2-out-of-3 pediatric DLGNT patients survive beyond one decade. Chemotherapy is statistically associated with longer survival in DLGNT pediatric patients and should form the core of any treatment regimen in this setting. Early detection by means of judicious imaging and surgical biopsy for tissue diagnosis can lead to earlier treatment and likely superior outcomes.
- Published
- 2022
20. Transcortical resection of a giant bilobed falcine meningioma
- Author
-
Turki Elarjani, Evan Luther, Alexis A. Morell, Daniel G. Eichberg, Ashish H. Shah, Victor M. Lu, Gurvinder Kaur, Michael E. Ivan, and Ricardo J. Komotar
- Subjects
Surgery ,Neurology (clinical) ,General Medicine - Abstract
Falcine meningiomas present significant surgical challenges because they often involve the falx bilaterally, are concealed by a significant amount of normal brain parenchyma and are frequently deep in location and in close proximity to the anterior cerebral arteries. Many prefer the interhemispheric approach for these lesions, but this operative corridor is not without risk as venous infarctions and cortical injury can occur.We present an alternative technique utilizing a transcortical approach to resect a giant, bilobed falcine meningioma in a 68-year-old female who presented with progressive abulia, urinary incontinence, and bilateral lower extremity weakness over 2 years. A unilateral right frontal craniotomy and a corticectomy through the right superior frontal gyrus was used to safely resect the entire tumor. The patient tolerated the procedure well and was discharged home without issue. Pathology demonstrated that the lesion was an atypical meningioma and she subsequently received adjuvant fractionated radiotherapy. At 2-year follow-up, she has no neurologic deficits, never developed any postoperative seizures and has not had any evidence of tumor recurrence.The transcortical approach can be used as a safe alternative for resecting falcine meningiomas without adding significant undue risk to the patient.
- Published
- 2022
21. Frontal lobe low-grade tumors seizure outcome: a pooled analysis of clinical predictors
- Author
-
Martín A. Merenzon, Shovan Bhatia, Adam Levy, Tiffany Eatz, Alexis A. Morell, Lekhaj C. Daggubati, Evan Luther, Ashish H. Shah, Ricardo J. Komotar, and Michael E. Ivan
- Subjects
Surgery ,Neurology (clinical) ,General Medicine - Published
- 2023
- Full Text
- View/download PDF
22. Frameless Robotic-Assisted Biopsy of Pediatric Brainstem Lesions: A Systematic Review and Meta-Analysis of Efficacy and Safety
- Author
-
Victor M, Lu, Stefan W, Koester, Long, Di, Turki, Elarjani, Evan M, Luther, Daniel G, Eichberg, Alexis A, Morell, Christopher S, Graffeo, Othman, Bin-Alamer, Hussam, Abou-Al-Shaar, Ricardo J, Komotar, Michael E, Ivan, and Ashish H, Shah
- Subjects
Surgery ,Neurology (clinical) - Abstract
Pediatric brainstem lesions are diagnoses that require tissue sampling to advance our understanding of them and their management. Frameless, robot-assisted biopsy of these lesions has emerged as a novel, viable biopsy approach. Correspondingly, the aim of this study was to quantitively and qualitatively summarize the contemporary literature regarding the likelihood of achieving tumor diagnosis and experiencing any postoperative complications.Searches of 7 electronic databases from inception to September 2022 were conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Articles were screened against prespecified criteria. Outcomes were pooled by random-effects meta-analyses of proportions where possible.A total of 8 cohort studies satisfied all criteria. They described 99 pediatric patients with brainstem lesions in whom frameless, robot-assisted biopsy was involved in their work-up. There were 62 (63%) male and 37 (37%) female patients with a median age of 9 years at time of biopsy. Overall, all patients had sufficient tissue obtained by initial biopsy for evaluation. Pooled estimate of achieving tumor diagnosis was 100% (95% confidence interval [CI] 97%-100%) across all studies with a high degree of certainty. Across all studies, there were no cases of procedure-related mortality. The pooled estimates of transient and permanent complications after biopsy were 10% (95% CI 4%-19%) and 0% (95% CI 0%-2%), respectively, of very low and low degrees of certainty each.The contemporary metadata demonstrates the frameless, robot-assisted biopsy of pediatric brainstem lesions is both effective and safe when performed in an experienced setting. Further research is needed to augment robot and automated technologies into workup algorithms.
- Published
- 2023
- Full Text
- View/download PDF
23. Transcatheter Closure of Patent Foramen Ovale
- Author
-
Richard A. Krasuski, Ashish H. Shah, and Rishi Puri
- Subjects
Adult ,Male ,medicine.medical_specialty ,Foramen ovale patent ,Adolescent ,business.industry ,Closure (topology) ,Foramen Ovale, Patent ,Middle Aged ,medicine.disease ,Surgery ,Embolic stroke ,Young Adult ,Physiology (medical) ,medicine ,Patent foramen ovale ,Humans ,Female ,Cardiology and Cardiovascular Medicine ,business - Published
- 2021
- Full Text
- View/download PDF
24. Augmented Reality for Enhancing Image-Guided Neurosurgery: Superimposing the Future onto the Present
- Author
-
Daniel G. Eichberg, Michael E. Ivan, Long Di, Ashish H. Shah, Evan M. Luther, Victor M. Lu, Ricardo J. Komotar, and Timur M. Urakov
- Subjects
Augmented Reality ,Surgery, Computer-Assisted ,Neurosurgery ,Humans ,Surgery ,Neurology (clinical) ,Neurosurgical Procedures - Published
- 2021
25. Multiple Iterations of Magnetic Resonance-Guided Laser Interstitial Thermal Ablation of Brain Metastases: Single Surgeon's Experience and Review of the Literature
- Author
-
Evan Luther, Ricardo J. Komotar, Simon A. Menaker, Daniel G Eichberg, Michael E. Ivan, Ashish H. Shah, Long Di, Alexa Semonche, Walter J. Jermakowicz, and Aria M. Jamshidi
- Subjects
medicine.medical_specialty ,Magnetic Resonance Spectroscopy ,Brain tumor ,Fluid-attenuated inversion recovery ,03 medical and health sciences ,0302 clinical medicine ,Edema ,medicine ,Humans ,Contraindication ,Retrospective Studies ,Surgeons ,medicine.diagnostic_test ,Cerebrospinal fluid leak ,Brain Neoplasms ,business.industry ,Lasers ,Magnetic resonance imaging ,medicine.disease ,030220 oncology & carcinogenesis ,Brain lesions ,Surgery ,Laser Therapy ,Neurology (clinical) ,Radiology ,medicine.symptom ,business ,Complication ,030217 neurology & neurosurgery - Abstract
Background Prior treatment with magnetic resonance-guided, laser-induced thermal therapy (LITT) is widely assumed not to be a contraindication for further treatment of brain lesions, including further iterations of LITT. However, the safety and efficacy of repeat LITT treatments have never been formally investigated. Objective To evaluate treatment with multiple iterations of LITT. Methods All patients treated with LITT at least twice at our institution were included in the study. Outcomes and neurological examinations from before and after surgery were retrospectively examined from clinic notes. Perilesonal edema was determined at various timepoints using volumetric data derived from manual tracings of fluid-attenuated inversion recovery (FLAIR) enhancement on magnetic resonance imaging (MRI). Finally, a literature review of prior cases of repeat LITT was performed. Results A total of 9 patients underwent 18 treatments with LITT; all but 1 of whom were treated for metastatic brain lesions. One patient had a transient cerebrospinal fluid leak, whereas a second patient had a superficial wound infection, both of which resolved with standard medical care. The remaining 7 patients tolerated all LITT procedures without complication. Analysis of perilesional edema volume demonstrated a correlation with the amount of energy delivered during LITT. Literature review found 5 published papers describing 9 patients who underwent LITT more than once, the majority of whom tolerated repeat LITT well. Conclusion LITT is a safe and promising treatment modality and may be used multiple times without issue. There appears to be an association between the amount of energy delivered during a LITT session and the degree of postoperative perilesional edema.
- Published
- 2019
- Full Text
- View/download PDF
26. The Role of Laser Interstitial Thermal Therapy in Surgical Neuro-Oncology: Series of 100 Consecutive Patients
- Author
-
Veronica Borowy, Alexa Semonche, Evan Luther, Ashish H. Shah, Michael E. Ivan, Anil K. Mahavadi, Christopher A. Sarkiss, Daniel G Eichberg, Alexis Morell, and Ricardo J. Komotar
- Subjects
Adult ,Male ,medicine.medical_specialty ,Brain tumor ,Single Center ,Metastasis ,Cohort Studies ,Stereotaxic Techniques ,Laser Interstitial Thermal Therapy ,Glioma ,medicine ,Humans ,Survival analysis ,Retrospective Studies ,Brain Neoplasms ,business.industry ,Middle Aged ,medicine.disease ,Surgery ,Treatment Outcome ,Female ,Laser Therapy ,Neurology (clinical) ,Neurosurgery ,business ,Cohort study - Abstract
Laser interstitial thermal therapy (LITT) is an adjuvant treatment for intracranial lesions that are treatment refractory or in deep or eloquent brain. Initial studies of LITT in surgical neuro-oncology are limited in size and follow-up.To present our series of LITT in surgical neuro-oncology to better evaluate procedural safety and outcomes.An exploratory cohort study of all patients receiving LITT for brain tumors by a single senior neurosurgeon at a single center between 2013 and 2018. Primary outcomes included extent of ablation (EOA), time to recurrence (TTR), local control at 1-yr follow-up, and overall survival (OS). Secondary outcomes included complication rate. Outcomes were compared by tumor subtype. Predictors of outcomes were identified.A total of 91 patients underwent 100 LITT procedures; 61% remain alive with 72% local control at median 7.2 mo follow-up. Median TTR and OS were 31.9 and 16.9 mo, respectively. For lesion subtypes, median TTR (months, not applicable [N/A] if50% rate observed), local control rates at 1-yr follow-up, and median OS (months) were the following: dural-based lesions (n = 4, N/A, 75%, 20.7), metastases (n = 45, 55.9, 77.4%, 16.9), newly diagnosed glioblastoma (n = 11, 31.9, 83.3%, 32.3), recurrent glioblastoma (n = 14, 5.6, 24.3%, 7.3), radiation necrosis (n = 20, N/A, 67.2%, 16.4), and other lesions (n = 6, 12.3, 80%, 24.4). TTR differed by tumor subtype (P = .02, log-rank analysis). EOA predicted local control (P = .009, multivariate proportional hazards regression); EOA85% predicted longer TTR (P = .006, log-rank analysis). Complication rate was 4%.Our series of LITT in surgical neuro-oncology, 1 of the largest to date, further evidences its safety and outcomes profile.
- Published
- 2019
- Full Text
- View/download PDF
27. Analysis of intra-operative variables as predictors of 30-day readmission in patients undergoing glioma surgery at a single center
- Author
-
Ashish H. Shah, Iahn Cajigas, Veronica Borowy, Ricardo J. Komotar, Nathalie Abitbol, Richard H. Epstein, Michael E. Ivan, and Anil K. Mahavadi
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Neurology ,Multivariate analysis ,Single Center ,Patient Readmission ,Risk Assessment ,Neurosurgical Procedures ,Intraoperative Period ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Glioma ,Humans ,Medicine ,In patient ,Aged ,Retrospective Studies ,Receiver operating characteristic ,business.industry ,Supratentorial Neoplasms ,Glioma surgery ,Middle Aged ,medicine.disease ,Surgery ,Oncology ,030220 oncology & carcinogenesis ,Female ,Neurology (clinical) ,Neurosurgery ,business ,030217 neurology & neurosurgery - Abstract
Reducing the time from surgery to adjuvant chemoradiation, by decreasing unnecessary readmissions, is paramount for patients undergoing glioma surgery. The effects of intraoperative risk factors on 30-day readmission rates for such patients is currently unclear. We utilized a predictive model-driven approach to assess the impact of intraoperative factors on 30-day readmission rates for the cranial glioma patient. Retrospectively, the intraoperative records of 290 patients who underwent glioma surgery at a single institution by a single surgeon were assessed. Data on operative variables including anesthesia specific factors were analyzed via univariate and stepwise regression analysis for impact on 30-day readmission rates. A predictive model was built to assess the capability of these results to predict readmission and validated using leave-one-out cross-validation. In multivariate analysis, end case hypothermia (OR 0.28, 95% CI [0.09, 0.84]), hypertensive time > 15 min (OR 2.85, 95% CI [1.21, 6.75]), and pre-operative Karnofsky performance status (KPS) (OR 0.63, 95% CI [0.41, 0.98] were identified as being significantly associated with 30-day readmission rates (chi-squared statistic vs. constant model 25.2, p
- Published
- 2019
- Full Text
- View/download PDF
28. Preoperative Magnetic Resonance Imaging Based Predictive Modeling of Brain Tumor Laser Ablation
- Author
-
Ghulam Farooq, Jonathan R. Jagid, Michael E. Ivan, Iahn Cajigas, Walter J. Jermakowicz, Santiago Guerra, Anil K. Mahavadi, Ashish H. Shah, Ricardo J. Komotar, and Lia Dan
- Subjects
Nuclear magnetic resonance ,Laser ablation ,medicine.diagnostic_test ,business.industry ,medicine ,Brain tumor ,Surgery ,Magnetic resonance imaging ,Neurology (clinical) ,medicine.disease ,business - Published
- 2019
- Full Text
- View/download PDF
29. Use of Tubular Retractors for Minimally Invasive Resection of Deep-Seated Cavernomas
- Author
-
Ashish H. Shah, Ricardo J. Komotar, Long Di, Robert M. Starke, Daniel G Eichberg, and Michael E. Ivan
- Subjects
Microsurgery ,medicine.medical_specialty ,Brain Neoplasms ,business.industry ,Brain ,medicine.disease ,Gross Total Resection ,Preoperative care ,Neurosurgical Procedures ,Surgery ,Resection ,Retractor ,Safety profile ,Epilepsy ,Hemangioma, Cavernous ,medicine ,Seizure control ,Humans ,Neurology (clinical) ,Cortical surface ,business - Abstract
Cavernomas located in subcortical or eloquent locations are difficult lesions to access safely. Tubular retractors, which distribute retraction pressure radially, have been increasingly employed successfully. These retractors may be beneficial in subcortical cavernoma resection.To review a single institution's case series to determine the safety profile and efficacy of transcortical-transtubular cavernoma resections and to describe our transtubular operative technique.We reviewed a single institution's transcortical-transtubular cavernoma resections using either BrainPath (NICO, Indianapolis, Indiana) or ViewSite Brain Access System (Vycor Medical, Boca Raton, Florida) tubular retractors performed from 2013 to 2018 (n = 20).Gross total resection was achieved in all patients. When a developmental venous anomaly (DVA) was present, avoidance of DVA resection was achieved in all cases (n = 4). All patients had a supratentorial cavernoma with mean depth below cortical surface of 44.1 mm. Average postoperative clinical follow-up was 20.4 wk. Early neurologic deficit rate was 10% (n = 2); permanent neurologic deficit rate was 0%. One patient (5%) experienced early postoperative seizures ( 1 wk postop). No patients experienced late seizures ( 1 wk follow-up). Engel class 1 seizure control at final clinical follow-up was achieved in 87.5% of patients presenting with preoperative epilepsy.Tubular retractors provide a low-profile, minimally invasive operative corridor for resection of subcortical cavernomas. There were no permanent neurologic complications in our series of 20 cases, and long-term seizure control was achieved in all patients. Thus, tubular retractors appear to be a safe and efficacious tool for resection of subcortical cavernomas.
- Published
- 2019
- Full Text
- View/download PDF
30. Parasagittal and parafalcine meningiomas: integral strategy for optimizing safety and retrospective review of a single surgeon series
- Author
-
Amanda M. Casabella, Ricardo J. Komotar, Simon A. Menaker, Ashish H. Shah, and Daniel G Eichberg
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Brain tumor ,Radiosurgery ,Meningioma ,03 medical and health sciences ,0302 clinical medicine ,Meningeal Neoplasms ,medicine ,Humans ,Embolization ,Craniotomy ,Retrospective Studies ,Surgeons ,Parasagittal Meningioma ,business.industry ,General Medicine ,Perioperative ,Middle Aged ,medicine.disease ,Surgery ,Treatment Outcome ,030220 oncology & carcinogenesis ,Neurology (clinical) ,Neoplasm Recurrence, Local ,business ,030217 neurology & neurosurgery ,Superior sagittal sinus - Abstract
Background: Parafalcine and parasagittal meningiomas present unique challenges for resection. Although maximal safe resection is the primary goal of surgical management for these lesions, venous infarction and eloquent cortical structure damage occur in up to 14% of cases. Therefore, optimal preoperative planning and intraoperative technique is critical.Methods: We retrospectively reviewed a single surgeon's case series with resection of 58 parafalcine and parasagittal meningiomas. Operative strategy included not crossing the superior sagittal sinus (SSS) during craniotomy, not resecting the falx, use of motor evoked potentials (MEPs) to avoid damage to eloquent brain, and selective use of preoperative embolization.Results: Fifty-eight patients, 45 with parasagittal meningiomas and 13 with parafalcine meningiomas were evaluated. Median age 58.34 years and mean follow-up was 7.7 months. Gross total resection (GTR) was achieved in 51.7% of patients and near-gross total resection rate was 48.3%. Postoperative day one discharge rate was 62.1%. Complication rate was 8.6%, with new postoperative neurologic deficit rate of 5.2%. Tumor recurrence/growth documented on postoperative imaging rate was 3.4%.Conclusions: In our series of parasagittal and parafalcine meningioma resection, we report a 51.7% GTR rate associated with a low complication rate. Techniques to minimize perioperative morbidity include not crossing the SSS on craniotomy, avoiding falx resection, using MEPs, and selective preoperative embolization to optimize the chance of a maximal safe resection. We utilize a strategy of conservative initial tumor resection focused on maximizing the chances of a favorable neurologic outcome, followed as necessary by adjuvant therapies such as radiosurgery and salvage therapies such as laser interstitial thermal therapy, although longer follow-up comparable to that of series with more radical approaches is required to determine if long term outcomes are comparable.
- Published
- 2019
- Full Text
- View/download PDF
31. Salvage craniotomy for treatment-refractory symptomatic cerebral radiation necrosis
- Author
-
Christopher A. Sarkiss, Daniel G Eichberg, Ashish H. Shah, Alexa Semonche, Evan Luther, Ricardo J. Komotar, Michael E. Ivan, Alexis Morell, and Anil K. Mahavadi
- Subjects
medicine.medical_specialty ,Bevacizumab ,business.industry ,medicine.medical_treatment ,Medical record ,Brain tumor ,Medicine (miscellaneous) ,Original Articles ,medicine.disease ,Preoperative care ,Radiosurgery ,Surgery ,Radiation therapy ,Glioma ,Medicine ,business ,Craniotomy ,medicine.drug - Abstract
Background The incidence of symptomatic radiation necrosis (RN) has risen as radiotherapy is increasingly used to control brain tumor progression. Traditionally managed with steroids, symptomatic RN can remain refractory to medical treatment, requiring surgical intervention for control. The purpose of our study was to assess a single institution’s experience with craniotomy for steroid-refractory pure RN. Methods The medical records of all tumor patients who underwent craniotomies at our institution from 2011 to 2016 were retrospectively reviewed for a history of preoperative radiotherapy or radiosurgery. RN was confirmed histopathologically and patients with active tumor were excluded. Preoperative, intraoperative, and outcome information was collected. Primary outcomes measured were postoperative KPS and time to steroid freedom. Results Twenty-four patients with symptomatic RN were identified. Gross total resection was achieved for all patients. Patients with metastases experienced an increase in KPS (80 vs 100, P < .001) and required a shortened course of dexamethasone vs patients with high-grade gliomas (3.4 vs 22.2 weeks, P = .003). RN control and neurological improvement at 13.3 months’ follow-up were 100% and 66.7%, respectively. Adrenal insufficiency after rapidly tapering dexamethasone was the only morbidity (n = 1). Overall survival was 93.3% (14/15) at 1 year. Conclusion In cases of treatment-refractory symptomatic RN, resection can lead to an overall improvement in postoperative health status and neurological outcomes with minimal RN recurrence. Craniotomy for surgically accessible RN can safely manage symptomatic patients, and future studies assessing the efficacy of resection vs bevacizumab may be warranted.
- Published
- 2019
- Full Text
- View/download PDF
32. Multimodal management of pediatric carotid body tumors: a systematic review and case illustrations
- Author
-
Sarah Jernigan, Manish Kuchakulla, Ashish H. Shah, Toba N. Niazi, Valerie Armstrong, and Sanjiv Bhatia
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Vertebral artery ,Neck mass ,External carotid artery ,030204 cardiovascular system & hematology ,Carotid Body Tumor ,03 medical and health sciences ,Postoperative Complications ,Rare Diseases ,0302 clinical medicine ,Paraganglioma ,medicine.artery ,Preoperative Care ,medicine ,Humans ,Anesthesia ,030212 general & internal medicine ,Embolization ,Child ,Retrospective Studies ,Neck pain ,Neck Pain ,business.industry ,General Medicine ,medicine.disease ,Combined Modality Therapy ,Embolization, Therapeutic ,Dysphagia ,Cranial Nerve Diseases ,Surgery ,Child, Preschool ,Female ,medicine.symptom ,Internal carotid artery ,Deglutition Disorders ,business - Abstract
OBJECTIVE Carotid body tumors (CBTs), extraadrenal paragangliomas, are extremely rare neoplasms in children that often require multimodal surgical treatment, including preoperative anesthesia workup, embolization, and resection. With only a few cases reported in the pediatric literature, treatment paradigms and surgical morbidity are loosely defined, especially when carotid artery infiltration is noted. Here, the authors report two cases of pediatric CBT and provide the results of a systematic review of the literature. METHODS The study was divided into two sections. First, the authors conducted a retrospective review of our series of pediatric CBT patients and screened for patients with evidence of a CBT over the last 10 years (2007–2017) at a single tertiary referral pediatric hospital. Second, they conducted a systematic review, according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, of all reported cases of pediatric CBTs to determine the characteristics (tumor size, vascularity, symptomatology), treatment paradigms, and complications. RESULTS In the systematic review (n = 21 patients [includes 19 cases found in the literature and 2 from the authors’ series]), the mean age at diagnosis was 11.8 years. The most common presenting symptoms were palpable neck mass (62%), cranial nerve palsies (33%), cough or dysphagia (14%), and neck pain (19%). Metastasis occurred only in 5% of patients, and 19% of cases were recurrent lesions. Only 10% of patients presented with elevated catecholamines and associated sympathetic involvement. Preoperative embolization was utilized in 24% of patients (external carotid artery in 4 and external carotid artery and vertebral artery in 1). Cranial nerve palsies (cranial nerve VII [n = 1], IX [n = 1], X [n = 4], XI [n = 1], and XII [n = 3]) were the most common cause of surgical morbidity (33% of cases). The patients in the authors’ illustrative cases underwent preoperative embolization and balloon test occlusion followed by resection, and both patients suffered from transient Horner’s syndrome after embolization. CONCLUSIONS Surgical management of CBTs requires an extensive preoperative workup, anesthesia, and multimodal surgical management. Due to a potentially high rate of surgical morbidity and vascularity, balloon test occlusion with embolization may be necessary in select patients prior to resection. Careful thorough preoperative counseling is vital to preparing families for the intensive management of these children. ABBREVIATIONS BTO = balloon test occlusion; CBT = carotid body tumor; CN = cranial nerve; ECA = external carotid artery; ICA = internal carotid artery; MIBG = iodine-123-meta-iodobenzylguanidine; PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
- Published
- 2019
- Full Text
- View/download PDF
33. Utility of Magnetic Resonance Perfusion Imaging in Quantifying Active Tumor Fraction and Radiation Necrosis in Recurrent Intracranial Tumors
- Author
-
Manish Kuchakulla, Michael E. Ivan, Ricardo J. Komotar, George M. Ibrahim, Ashish H. Shah, Sakir H. Gultekin, and Eesh Dadheech
- Subjects
Adult ,Male ,medicine.medical_treatment ,Metastasis ,Necrosis ,03 medical and health sciences ,0302 clinical medicine ,Biopsy ,Image Processing, Computer-Assisted ,Humans ,Medicine ,Radiation Injuries ,Aged ,Retrospective Studies ,medicine.diagnostic_test ,Brain Neoplasms ,business.industry ,McDonald criteria ,Histology ,Middle Aged ,medicine.disease ,Radiation therapy ,Radiation necrosis ,Cerebral blood flow ,Cerebrovascular Circulation ,030220 oncology & carcinogenesis ,Linear Models ,Female ,Surgery ,Neurology (clinical) ,Neoplasm Recurrence, Local ,Glioblastoma ,business ,Nuclear medicine ,Magnetic Resonance Angiography ,030217 neurology & neurosurgery ,Follow-Up Studies - Abstract
Background Ancillary criteria to identify tumor recurrence such as the McDonald criteria or Response Assessment in Neuro-Oncology criteria can provide false diagnoses. Magnetic resonance perfusion (MRP) imaging has been proposed to differentiate post-treatment changes from recurrence. We investigated the utility of MRP to quantify the histological fraction of active tumor (AT), treatment-related changes, and radiation necrosis in recurrent post-treatment intracranial tumors. Methods We conducted an exploratory single-blind study of patients with intracranial glioblastoma or metastases with previous radiation therapy and MRP before surgery. Biopsy specimens (n = 19) were analyzed for the percentage of AT, radiation necrosis, and treatment effect. Nonparametric Spearman's rho analysis and multivariable analysis of covariance were performed to assess the correlation between quantitative MRP and AT histological fraction. Results The mean patient age was 58 ± 11.5 years. The mean relative cerebral blood volume (rCBV) and relative cerebral blood flow (rCBF) were 1.33 ± 0.71 and 1.34 ± 0.73, respectively. On analysis of covariance, significant associations were identified between increased rCBF (P = 0.0004) and increased rCBV (P = 0.007) and percentage of AT. A significant interaction was identified between rCBF and rCBV and tumor histological features (glioblastoma vs. metastases; P = 0.003 and P = 0.03, respectively). An rCBF >1 predicted a mean AT fraction of ≥53% for all intracranial tumors and 74% for glioblastoma. Conclusion MRP can help quantitatively predict tumor recurrence and/or progression for glioblastomas. The AT histological fraction correlated with quantitative radiologic measurements, including rCBV and rCBF. For metastases, MRP might not be as useful in predicting the AT fraction. Clinicians must be judicious with their use of MRP in predicting tumor recurrence and radiation necrosis.
- Published
- 2019
- Full Text
- View/download PDF
34. Positive predictive value and trends of inferior petrosal sinus sampling (IPSS) in diagnosing cushing disease and ectopic ACTH secretion: A systematic review and meta-analysis
- Author
-
Vaidya, Govindarajan, Victor M, Lu, Jamie E, Clarke, Evan M, Luther, Daniel G, Eichberg, Alexis A, Morell, Ashish H, Shah, Robert M, Starke, Atil Y, Kargi, Ricardo J, Komotar, and Michael E, Ivan
- Subjects
Diagnosis, Differential ,ACTH Syndrome, Ectopic ,Adrenocorticotropic Hormone ,Predictive Value of Tests ,Humans ,Deamino Arginine Vasopressin ,Surgery ,Neurology (clinical) ,General Medicine ,Petrosal Sinus Sampling ,Pituitary ACTH Hypersecretion ,Cushing Syndrome - Abstract
Inferior petrosal sinus sampling (IPSS) offers a means of differentiating between Cushing disease and Cushing syndrome with lower false-positive and false-negative rates relative to traditional techniques. However, consolidated data on efficiency reflecting contemporary use is lacking. We present a comprehensive meta-analysis of IPSS as a means of diagnosing ACTH-cortisol axis derangements via both CRH and desmopressin-stimulated techniques.Searches of 7 electronic databases from inception to December 2020 were conducted following PRISMA guidelines. Articles were screened against pre-specified criteria. Outcomes were pooled by random-effects meta-analyses of proportions where possible. We performed a meta-analysis of sixty-eight unique publications, assessing each technique for positive predictive value (PPV), false positive rates, and overall changes in practice patterns over time.A total of 68 studies satisfied all criteria, with 3685 (3471, 94.2% confirmed) and 332 (285, 85.8% confirmed) patients tested for Cushing's disease and syndrome, respectively. Pooled analyses demonstrated an overall PPV of 89.3% (95%CI[83.6%, 94.0%]) in CRH stimulation diagnosis of Cushing disease. In desmopressin stimulation, our analyses demonstrated an overall PPV of 96.5% (95%CI[94.5%, 98.1%]) in diagnosis of Cushing disease. There was a significant decline in the use of CRH-stimulation IPSS in diagnosis of both Cushing disease (p = 0.0055) and Cushing syndrome (p = 0.013). Concurrently, there was a significant increase in the use of desmopressin-stimulation IPSS in diagnosis of both pathologies (p lt; 0.0001).Our findings demonstrate significant changes in practice patterns with respect to IPSS stimulation technique. Our pooled analyses demonstrate improved diagnostic performance in desmopressin stimulation procedures relative to CRH stimulation procedures. Further multi-institutional studies with special attention to acquiring quality data for sensitivity, specificity, and other critical analyses are necessary to truly evaluate this promising technique.
- Published
- 2022
- Full Text
- View/download PDF
35. The Emerging Relevance of H3K27 Trimethylation Loss in Meningioma: A Systematic Review of Recurrence and Overall Survival with Meta-Analysis
- Author
-
Victor M. Lu, Evan M. Luther, Daniel G. Eichberg, Alexis A. Morell, Ashish H. Shah, Ricardo J. Komotar, and Michael E. Ivan
- Subjects
Histones ,Male ,Survival Rate ,Meningeal Neoplasms ,Humans ,Female ,Surgery ,Neurology (clinical) ,Middle Aged ,Meningioma ,Prognosis ,Methylation - Abstract
It has been proposed in the most recent 2021 World Health Organization classification of brain tumors that the loss of trimethylation at histone 3 lysine site 27 (H3K27me3) might prognosticate meningioma outcomes. However, to date, the emerging literature has remained diffuse in its stance. Thus, the aim of the present study was to determine the prognostic relevance of H3K27me3 loss in meningioma.Searches of 7 electronic databases from inception to October 2021 were conducted in accordance with the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. Articles were screened against prespecified criteria. Outcomes were pooled by random effects meta-analyses of proportions, where possible.A total of 7 retrospective cohort studies satisfied all the criteria, with a total of 2180 meningioma patients overall (1291 male patients [59%]; mean age, 56 years). Across all 7 studies, the pooled incidence of H3K27me3 loss was estimated at 15% (95% confidence interval, 8%-24%). Across 6 studies, the pooled multivariate-derived hazard ratio estimate for recurrence was 1.77 (95% confidence interval, 1.23-2.31; P0.01). Overall survival on univariate analysis was significantly shorter with H3K27me3 loss in 2 of 4 studies (50%), and 2 studies had described a significant association between H3K27me3 loss and shorter overall survival on multivariate analysis.The contemporary metadata favor a greater incidence of meningioma recurrence based independently on H3K27me3 loss, with a statistically significant difference. It is possible that these effects are more pronounced for grade 2 meningiomas; however, more robust data and analysis are needed to augment this position.
- Published
- 2022
- Full Text
- View/download PDF
36. A Cohort Study on Prognostic Factors for Laser Interstitial Thermal Therapy Success in Newly Diagnosed Glioblastoma
- Author
-
Ricardo J. Komotar, Christopher P Wang, Alexander D. Sanjurjo, Walter J. Jermakowicz, Daniel G Eichberg, Alexa Semonche, Ashish H. Shah, Evan Luther, Long Di, and Michael E. Ivan
- Subjects
medicine.medical_specialty ,Multivariate analysis ,medicine.medical_treatment ,Urology ,Preoperative care ,Cohort Studies ,medicine ,Humans ,Retrospective Studies ,Chemotherapy ,medicine.diagnostic_test ,business.industry ,Proportional hazards model ,Brain Neoplasms ,Lasers ,Magnetic resonance imaging ,Prognosis ,Chemotherapy regimen ,Research—Human—Clinical Studies ,Cohort ,Surgery ,Neurology (clinical) ,Laser Therapy ,business ,Glioblastoma ,Cohort study - Abstract
Background Laser interstitial thermal therapy (LITT) is a promising approach for cytoreduction of deep-seated gliomas. However, parameters contributing to treatment success remain unclear. Objective To identify extent of ablation (EOA) and time to chemotherapy (TTC) as predictors of improved overall and progression-free survival (OS, PFS) and suggest laser parameters to achieve optimal EOA. Methods Demographic, clinical, and survival data were collected retrospectively from 20 patients undergoing LITT for newly diagnosed glioblastoma (nGBM). EOA was calculated through magnetic resonance imaging-based volumetric analysis. Kaplan-Meier and multivariate Cox regression were used to examine the relationship between EOA with OS and PFS accounting for covariates (age, isocitrate dehydrogenase-1 (IDH1) mutation, O6-methylguanine-DNA methyltransferase hypermethylation). The effect of laser thermodynamic parameters (power, energy, time) on EOA was identified through linear regression. Results Median OS and PFS for the entire cohort were 36.2 and 3.5 mo respectively. Patient's with >70% EOA had significantly improved PFS compared to ≤70% EOA (5.2 vs 2.3 mo, P = .01) and trended toward improved OS (36.2 vs 11 mo, P = .07) on univariate and multivariate analysis. Total laser power was a significant predictor for increased EOA when accounting for preoperative lesion volume (P = .001). Chemotherapy within 16 d of surgery significantly predicted improved PFS compared to delaying chemotherapy (9.4 vs 3.1 mo, P = .009). Conclusion Increased EOA was a predictor of improved PFS with evidence of a trend toward improved OS in LITT treatment of nGBM. A strategy favoring higher laser power during tumor ablation may achieve optimal EOA. Early transition to chemotherapy after LITT improves PFS.
- Published
- 2021
37. In Reply: Telemedicine in Neurosurgery: Lessons Learned From a Systematic Review of the Literature for the COVID-19 Era and Beyond
- Author
-
Daniel G Eichberg, Gregory W Basil, Long Di, Ashish H Shah, Evan M Luther, Victor M Lu, Maggy Perez-Dickens, Ricardo J Komotar, Allan D Levi, and Michael E Ivan
- Subjects
SARS-CoV-2 ,Neuros/4 ,AcademicSubjects/MED00930 ,Correspondence ,Neurosurgery ,COVID-19 ,Humans ,Surgery ,Neurology (clinical) ,Neurosurgical Procedures ,Telemedicine - Published
- 2021
38. Challenges in Diagnosis and Management of Previously Embolized Spinal Dural Arteriovenous Fistulae
- Author
-
Robert J. Rothrock, Victor M. Lu, Allan D. Levi, Clayton Haldeman, Efrat Saraf Lavi, Ashish H. Shah, and Eric C. Peterson
- Subjects
Male ,medicine.medical_specialty ,Fistula ,Radiography ,medicine.medical_treatment ,Spinal Cord Diseases ,medicine ,Humans ,Embolization ,Endovascular treatment ,Aged ,Retrospective Studies ,Central Nervous System Vascular Malformations ,medicine.diagnostic_test ,business.industry ,Open surgery ,Magnetic resonance imaging ,Middle Aged ,medicine.disease ,Embolization, Therapeutic ,Surgery ,Treatment Outcome ,Functional status ,Female ,Neurology (clinical) ,business ,Ligation ,Vascular Surgical Procedures - Abstract
Background Given the growing prevalence of initial endovascular treatment for type 1 spinal dural arteriovenous fistulae (dAVF), there are an increasing number of patients presenting with progressive symptoms related to recurrent previously embolized spinal dAVF. This study's goal was to identify demographic, clinical, and radiographic variables among patients who have failed embolization of type I spinal dAVF. Methods A retrospective review of 24 consecutive surgeries for type I spinal dAVF performed by the senior author (A.D.L.) identified 5 patients who underwent open surgery for failed embolization. These 5 cases were reviewed for location of fistula, time from embolization to recurrence, preoperative functional status, fistulous point encountered at surgery, and clinical outcome of the patient at 3-month follow-up. A representative example case is reviewed in detail. Results The median age at time of recurrence was 63 years (range 51–73 years). The median timing of embolization to recurrence of neurologic symptoms was 5 months (range 1–54) and to surgery 7 months (range 2–60 months). The level of the spinal dAVF was most frequently at T12–L1 (n = 3). Spinal magnetic resonance arteriography led to localization of the spinal dAVF in 2 patients and spinal catheter angiogram in 3 cases. All patients had definitive radiographic cure of the dAVF at last clinical follow-up. Conclusions The increased use of endovascular treatment of spinal dAVF has led to the treatment of refractory cases with a greater degree of surgical complexity. Open surgical ligation continues to provide the most definitive treatment outcomes for this complex spinal vascular entity.
- Published
- 2021
39. Perioperative Complications in Endoscopic Endonasal versus Transcranial Resections of Adult Craniopharyngiomas
- Author
-
Victor M. Lu, Gurvinder Kaur, Ricardo J. Komotar, Evan Luther, Ashish H. Shah, Alexis Morell, Michael E. Ivan, Vaidya Govindarajan, Joshua D. Burks, Hunter King, and Daniel G Eichberg
- Subjects
Adult ,Male ,Natural Orifice Endoscopic Surgery ,medicine.medical_specialty ,medicine.medical_treatment ,Nose ,Logistic regression ,Craniopharyngioma ,Postoperative Complications ,medicine ,Humans ,Pituitary Neoplasms ,Prospective cohort study ,Craniotomy ,Tumor size ,business.industry ,Mortality rate ,Perioperative ,Middle Aged ,medicine.disease ,Surgery ,Neuroendoscopy ,Female ,Neurology (clinical) ,Complication ,business - Abstract
Background Adult craniopharyngiomas are low-grade tumors of the pituitary infundibulum that can be locally aggressive and frequently present with profound visual deficits and endocrinopathies. Surgical resection remains the preferred initial treatment for these lesions, and recently endoscopic endonasal approaches (EEAs) have become increasingly used. However, minimal data exist comparing these techniques with traditional transcranial (TC) methods. The purpose of this study was to evaluate perioperative differences in EEA and TC approaches for adult craniopharyngiomas over the past several decades. Methods Craniopharyngioma surgeries in the Nationwide Inpatient Sample from 1998 to 2014 were identified. Complication rates, mortality rates, and annual treatment trends were stratified by procedure. Annual caseload was assessed with linear regression, and multivariate logistic regression models were created to determine predictors of inpatient mortality and perioperative complications. Results From 1998−2014, a significant increase in EEAs for craniopharyngiomas (+4.36/year, r2 = 0.80, P Conclusions Over the past several decades, utilization of EEAs to resect adult craniopharyngiomas has increased. EEAs appear to be associated with lower rates of perioperative mortality and complications. However, long-term, prospective studies controlling for tumor size, location, and preoperative symptomatology are needed to determine when one approach should be used preferentially over the other.
- Published
- 2021
40. Supralesional Ablation Volumes Are Feasible in the Posterior Fossa and May Provide Enhanced Symptomatic Relief
- Author
-
Ricardo J. Komotar, Ashish H. Shah, Gurvinder Kaur, Wendy Gaztanaga, Victor M. Lu, Evan Luther, Joshua D. Burks, Turki Elarjani, Daniel G Eichberg, Hunter King, Alexis Morell, Nikolas Echeverry, Samuel Mansour, David J McCarthy, and Michael E. Ivan
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Occipital bone ,Brain tumor ,Perioperative ,Hyperthermia, Induced ,Kaplan-Meier Estimate ,medicine.disease ,Ablation ,Preoperative care ,Symptomatic relief ,Progression-Free Survival ,Edema ,medicine ,Humans ,Surgery ,Neurology (clinical) ,Radiology ,Laser Therapy ,medicine.symptom ,business ,Brain metastasis - Abstract
Background Laser interstitial thermal therapy (LITT) for posterior fossa lesions remains rare as the small size of the infratentorial compartment, proximity to the brainstem, and thickness/angulation of the occipital bone creates barriers to procedural success. Furthermore, evaluation of the effect of ablation volume on outcomes is limited. Objective To analyze our institutional experience with LITT in the posterior fossa stratifying perioperative and long-term outcomes by ablation volumes. Methods Seventeen patients with posterior fossa lesions treated with LITT from 2013 to 2020 were identified. Local progression-free survival (PFS), overall survival, steroid dependence, and edema reduction were evaluated with Kaplan-Meier analysis grouped by ablation volume. Preoperative, postoperative, and last known Karnofsky Performance Status (KPS) were compared using a matched paired t test. Results No differences in pathology, preoperative KPS, or preoperative lesion volume were found between patients with total (100%-200% increase in pre-LITT lesion volume) versus radical (>200% increase in pre-LITT lesion volume) ablations. Patients who underwent radical ablation had a higher postoperative KPS (93 vs 82, P = .02) and higher KPS (94 vs 87, P = .04) and greater reduction in perilesional edema at last follow-up (P = .01). Median follow-up was 80.8 wk. Conclusion Despite obvious anatomical challenges, our results demonstrate that radical ablations are both feasible and safe in the posterior fossa. Furthermore, radical ablations may lead to greater decreases in perilesional edema and improved functional status both immediately after surgery and at last follow-up. Thus, LITT should be considered for patients with otherwise unresectable or radioresistant posterior fossa lesions.
- Published
- 2021
41. Rapid Intraoperative Diagnosis of Meningiomas using Stimulated Raman Histology
- Author
-
Evan Luther, Aria M. Jamshidi, Sakir H. Gultekin, You Jeong Park, Daniel G Eichberg, Long Di, Ricardo J. Komotar, Victor M. Lu, Michael E. Ivan, and Ashish H. Shah
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Nonlinear Optical Microscopy ,education ,Brain tumor ,Neurosurgical Procedures ,Meningioma ,03 medical and health sciences ,0302 clinical medicine ,Meningeal Neoplasms ,Medicine ,Frozen Sections ,Humans ,Medical diagnosis ,Prospective cohort study ,Permanent Section ,Frozen section procedure ,Intraoperative Care ,business.industry ,Brain Neoplasms ,Frozen Section Diagnosis ,Gold standard (test) ,Glioma ,medicine.disease ,body regions ,030220 oncology & carcinogenesis ,Surgery ,Female ,Neurology (clinical) ,Radiology ,business ,030217 neurology & neurosurgery - Abstract
Frozen section is a time- and labor-intensive method for intraoperative pathologic diagnosis. As a result, there exists a need to expedite and streamline the acquisition and interpretation of diagnostic histologic data to inform surgical decision making. Stimulated Raman histology (SRH) is an emerging technology that may serve to expedite the acquisition and interpretation of histologic data in the operating room.A blinded, prospective cohort study of 82 patients undergoing resection for tumors of the central nervous system was performed. Twenty-six patients with diagnoses of meningioma on SRH, frozen, or permanent section were included in this subanalysis. Diagnostic time and accuracy of stimulated SRH histology images were compared with the gold standard (frozen section). Agreement of SRH and frozen section diagnosis with permanent section (true) diagnosis was also compared.Mean time-to-diagnosis was significantly shorter for SRH-mediated diagnosis compared with frozen section (9.2 vs. 35.8, P0.0001). Diagnostic accuracy was not significantly different between methods (P = 0.15). Diagnostic agreement was not significantly different between SRH versus frozen, SRH versus permanent, or frozen versus permanent section methods (P = 0.5, P = 0.5, P = 1.00).SRH is a promising adjuvant technology that may expedite intraoperative neuropathologic consult without sacrificing diagnostic accuracy.
- Published
- 2021
42. Rapid Intraoperative Diagnosis of Gliomas Using Stimulated Raman Histology
- Author
-
Long Di, Daniel G Eichberg, Aria Jamshidi, Ashish H Shah, Evan Luther, Michael E Ivan, Ricardo J Komotar, and Sakir Gultekin
- Subjects
Surgery ,Neurology (clinical) - Published
- 2020
- Full Text
- View/download PDF
43. Novel Enhanced Recovery Protocol Optimizes Early Postoperative Outcomes in Patients Undergoing Supratentorial Craniotomy for Tumor Resection
- Author
-
Gregory D Brusko, Victor M Lu, Evan Luther, Daniel G Eichberg, Ashish H Shah, Ricardo J Komotar, and Michael E Ivan
- Subjects
Surgery ,Neurology (clinical) - Published
- 2020
- Full Text
- View/download PDF
44. Early Changes to Neurosurgery Resident Training During the COVID-19 Pandemic at a Large U.S. Academic Medical Center
- Author
-
Evan Luther, Vaidya Govindarajan, Ashish H. Shah, Allan D. Levi, Joshua D. Burks, and Ricardo J. Komotar
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Neurosurgery ,Personnel Staffing and Scheduling ,Clinical Neurology ,Neurosurgical Procedures ,03 medical and health sciences ,0302 clinical medicine ,Matched cohort ,Pandemic ,medicine ,Humans ,Academic Medical Centers ,business.industry ,Resident training ,COVID-19 ,Internship and Residency ,Residency program ,Surgical training ,United States ,Confidence interval ,Education, Medical, Graduate ,Elective Surgical Procedures ,030220 oncology & carcinogenesis ,Emergency medicine ,Florida ,Surgery ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
BACKGROUND: The coronavirus disease 2019 pandemic has led to sweeping changes in residency programs across the world, including cancellation of elective cases. The effects of safety measures on neurosurgical training remain unclear. To understand how neurosurgical residents have been affected, we analyzed the operative experience in the months leading up to and during the pandemic. METHODS: The resident and institutional case totals were tallied for a single residency program in Miami-Dade County from January 1, 2019 to June 30, 2020. A matched cohort analysis was performed before and during the pandemic to assess the effects on resident surgical training. RESULTS: The case totals for all levels of training were lower when restrictions were placed on elective surgeries. An average of 11 cases was logged in April 2020, a decrease from 26 cases in April 2019 (95% confidence interval, 8.7-22; P < 0.01). An average of 20 cases was logged in May 2020, a decrease from 25 cases in May 2019 (95% confidence interval, 1.2-8.8; P = 0.01). In April and May 2020, 299 (66%) and 148 (50%) fewer cases had been performed at our institution compared with April and May 2109. CONCLUSIONS: Operative experience was reduced for residents during the months when the performance of elective cases was restricted. Our data suggest experience in some areas of neurosurgery were more affected than were others, and residents at different levels of training were also affected differently. However, the extent of the coronavirus disease 2019 pandemic on neurosurgical training is unlikely to be understood in the short term.
- Published
- 2020
- Full Text
- View/download PDF
45. Geographic Disparities in Access to Glioblastoma Treatment Based on Hispanic Ethnicity in the United States
- Author
-
Ricardo J. Komotar, Daniel G Eichberg, Ashish H. Shah, Victor M. Lu, and Michael E. Ivan
- Subjects
business.industry ,medicine.medical_treatment ,Ethnic group ,Cancer ,medicine.disease ,Comorbidity ,Chemotherapy regimen ,Radiation therapy ,New england ,Hispanic ethnicity ,Medicine ,Surgery ,Neurology (clinical) ,business ,Demography ,Glioblastoma - Published
- 2020
- Full Text
- View/download PDF
46. When 'Peripheral' Becomes 'Central': Primary and Secondary Malignant Intracerebral Nerve Sheath Tumor: A Case Report and a Systematic Review
- Author
-
Evan Luther, Michael E. Ivan, Ali G Saad, David Kahn, Ashish H. Shah, Victor M. Lu, Ricardo J. Komotar, Daniel G Eichberg, and Franco Rubino
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Brain tumor ,Radiosurgery ,Nerve Sheath Neoplasms ,Lesion ,03 medical and health sciences ,0302 clinical medicine ,Peripheral Nervous System Neoplasms ,Medicine ,Humans ,Radical surgery ,Aged ,Spinal Neoplasms ,business.industry ,Middle Aged ,medicine.disease ,Prognosis ,Primary tumor ,Radiation therapy ,Nerve sheath tumor ,030220 oncology & carcinogenesis ,Surgery ,Female ,Neurology (clinical) ,Radiology ,medicine.symptom ,Neoplasm Recurrence, Local ,business ,030217 neurology & neurosurgery ,Brain metastasis - Abstract
Background The intracerebral occurrence of malignant peripheral nerve sheath tumors (MPNSTs) is exceedingly rare, and despite aggressive treatments, local recurrence and poor prognosis are very frequent. Like other brain tumors, these tumors could be primary or secondary, making the term "peripheral" an imprecise term for a primary brain tumor. Objective To analyze the reported cases of primary and secondary cerebral MPSNTs in terms of diagnosis, treatment, and overall survival. Additionally, we present a case of malignant intracerebral nerve sheath tumor (MINST) treated with radical surgery and radiotherapy. Methods Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, one database (PubMed) and crossed references were queried for MPNST with brain metastasis and primary MINSTs from 1971 to 2020. Data regarding demographic features, primary tumor site, risk factors, brain location of the lesion, treatment applied, and overall survival were extracted. Results A total of 55 patients were selected (including the reported case): 29 patients were secondary brain MPNST and 26 patients were primary MINST. The mean age was 41.8 ± 22 and 31.2 ± 23 yr, respectively. All brain metastases of MPNST (100%) had a primary tumor elsewhere in the body at the time of diagnosis. The overall survival was significantly shorter in patients with a secondary brain MPNST compared to MINST (P = .002). Conclusion We present a comprehensive analysis of every reported primary and secondary intracerebral MPNST. The prognosis in terms of survival is worst in the last one despite aggressive treatment. The lack of a primary MPNST in screening tests is sufficient to confirm a MINST at time of diagnosis.
- Published
- 2020
47. Clinical trials using oncolytic viral therapy to treat adult glioblastoma: a progress report
- Author
-
Michael E. Ivan, Daniel G Eichberg, Victor M. Lu, Frederic A. Vallejo, Sumedh S. Shah, Evan Luther, Ricardo J. Komotar, and Ashish H. Shah
- Subjects
Oncology ,Research Report ,medicine.medical_specialty ,Industry funding ,030218 nuclear medicine & medical imaging ,Viral vector ,Adult glioblastoma ,03 medical and health sciences ,0302 clinical medicine ,Glioma ,Internal medicine ,medicine ,Viral therapy ,Humans ,Oncolytic Virotherapy ,business.industry ,General Medicine ,medicine.disease ,Oncolytic virus ,Clinical trial ,Surgery ,Neurology (clinical) ,Completion time ,Neoplasm Recurrence, Local ,business ,Glioblastoma ,030217 neurology & neurosurgery - Abstract
OBJECTIVEAdult glioblastoma (GBM) has proven refractory to decades of innovation. Oncolytic viral therapy represents a novel therapy that uses viral vectors as both a delivery and therapeutic mechanism to target GBM cells. Despite the growing body of basic science data supporting the feasibility of viral therapy to treat GBM, the reporting of clinical trial results is heterogeneous. Correspondingly, the aim of this study was to present a contemporary summary of the progress all clinical trials have made to date.METHODSThe ClinicalTrials.gov database was reviewed in August 2020 for all possible interventional clinical trials involving viral vector–based therapy to treat adult GBM. These were then screened against selection criteria to identify pertinent clinical trials.RESULTSA total of 29 oncolytic viral therapy trials treating adult GBM were identified. The median start and expected completion years were 2014 and 2020, respectively. At the time of this writing, 10 (35%) trials were reported to have completed recruitment, whereas 7 (24%) were actively recruiting. The median target enrollment number was 36 (range 13–108), with the majority of trials being phase I (n = 18, 62%), and involving secondary GBM among other malignant glioma (n = 19, 66%). A total of 10 unique viral vectors were used across all trials, with the most common being adenovirus (n = 16, 55%). Only 2 (7%) phase I trials to date have reported outcomes on the ClinicalTrials.gov portal. Results of 12 additional clinical trials were found in academic publications, with median progression-free and overall survival times of 3 and 15 months, respectively, after the first viral dose at recurrence. The coordination of the large majority of trials originated from the US (n = 21, 72%), and the median number of testing sites per trial was 1 (range 1–15), via industry funding (n = 18 trials, 62%).CONCLUSIONSThere are multiple early-stage oncolytic viral therapy clinical trials for adult GBM currently active. To date, limited results and outcomes are promising but scarce. The authors expect this to change in the near future because many trials are scheduled to have either nearly or actually reached their expected recruitment completion time. How exactly oncolytic viral therapy will fit into the current treatment paradigms for primary and secondary GBM remains to be seen, and will not be known until safety and toxicity profiles are established by these clinical trials.
- Published
- 2020
48. Laser Ablation for Cerebral Metastases
- Author
-
Ashish H. Shah, Ricardo J. Komotar, David J McCarthy, Samuel Mansour, Evan Luther, Daniel G Eichberg, Michael Kader, Nikolas Echeverry, Katherine Berry, Michael E. Ivan, and Ahmed Nada
- Subjects
Target lesion ,medicine.medical_specialty ,medicine.medical_treatment ,Brain tumor ,03 medical and health sciences ,0302 clinical medicine ,Laser Interstitial Thermal Therapy ,Medicine ,Humans ,Minimally Invasive Surgical Procedures ,Craniotomy ,Laser ablation ,business.industry ,Brain Neoplasms ,Cellular death ,Brain ,General Medicine ,medicine.disease ,Treatment Outcome ,030220 oncology & carcinogenesis ,Surgery ,Neurology (clinical) ,Radiology ,Laser Therapy ,business ,Complication ,030217 neurology & neurosurgery ,Brain metastasis - Abstract
Laser interstitial thermal therapy is a minimally invasive surgical alternative to craniotomy that uses laser light through a fiber optic probe placed within a target lesion to create thermal tissue damage, resulting in cellular death. It is used in neuro-oncology to treat inaccessible lesions and obviate morbidity in high-risk patients. Overall complication rates and outcome measures are comparable with those seen in radiation and/or craniotomy. Laser interstitial thermal therapy can be an effective option for recurrent brain metastases. Prospective, randomized trials must be performed to evaluate the efficacy of laser interstitial thermal therapy as a primary treatment for brain metastases.
- Published
- 2020
49. Telemedicine in Neurosurgery: Lessons Learned from a Systematic Review of the Literature for the COVID-19 Era and Beyond
- Author
-
Evan Luther, Victor M. Lu, Ashish H. Shah, Daniel G Eichberg, Allan D. Levi, Michael E. Ivan, Maggy Perez-Dickens, Long Di, Gregory W. Basil, and Ricardo J. Komotar
- Subjects
medicine.medical_specialty ,Telemedicine ,020205 medical informatics ,AcademicSubjects/MED00930 ,Neurosurgery ,MEDLINE ,Clinical Neurology ,Review ,02 engineering and technology ,Telehealth ,Subspecialty ,03 medical and health sciences ,0302 clinical medicine ,0202 electrical engineering, electronic engineering, information engineering ,medicine ,Outpatient clinic ,Health policy ,Neuros/15 ,business.industry ,COVID-19 ,medicine.disease ,Stroke ,Coronavirus ,Systematic review ,Surgery ,Neurology (clinical) ,Medical emergency ,business ,030217 neurology & neurosurgery - Abstract
BACKGROUND Evolving requirements for patient and physician safety and rapid regulatory changes have stimulated interest in neurosurgical telemedicine in the COVID-19 era. OBJECTIVE To conduct a systematic literature review investigating treatment of neurosurgical patients via telemedicine, and to evaluate barriers and challenges. Additionally, we review recent regulatory changes that affect telemedicine in neurosurgery, and our institution's initial experience. METHODS A systematic review was performed including all studies investigating success regarding treatment of neurosurgical patients via telemedicine. We reviewed our department's outpatient clinic billing records after telemedicine was implemented from 3/23/2020 to 4/6/2020 and reviewed modifier 95 inclusion to determine the number of face-to-face and telemedicine visits, as well as breakdown of weekly telemedicine clinic visits by subspecialty. RESULTS A total of 52 studies (25 prospective and 27 retrospective) with 45 801 patients were analyzed. A total of 13 studies were conducted in the United States and 39 in foreign countries. Patient management was successful via telemedicine in 99.6% of cases. Telemedicine visits failed in 162 cases, 81.5% of which were due to technology failure, and 18.5% of which were due to patients requiring further face-to-face evaluation or treatment. A total of 16 studies compared telemedicine encounters to alternative patient encounter mediums; telemedicine was equivalent or superior in 15 studies. From 3/23/2020 to 4/6/2020, our department had 122 telemedicine visits (65.9%) and 63 face-to-face visits (34.1%). About 94.3% of telemedicine visits were billed using face-to-face procedural codes. CONCLUSION Neurosurgical telemedicine encounters appear promising in resource-scarce times, such as during global pandemics.
- Published
- 2020
- Full Text
- View/download PDF
50. Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection
- Author
-
Veronica Borowy, Alexander D. Sanjurjo, Michael E. Ivan, Evan Luther, Macarena I. de la Fuente, Ricardo J. Komotar, Long Di, Javier Figueroa, Ashish H. Shah, Daniel G Eichberg, Anil K. Mahavadi, and Alexa Semonche
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Brain tumor ,Fluid-attenuated inversion recovery ,Article ,Neurosurgical Procedures ,Lesion ,03 medical and health sciences ,0302 clinical medicine ,Glioma ,medicine ,Humans ,Survival analysis ,Aged ,Retrospective Studies ,business.industry ,Brain Neoplasms ,Middle Aged ,medicine.disease ,Prognosis ,Surgery ,Survival Rate ,Neurology ,Oncology ,030220 oncology & carcinogenesis ,Cohort ,Propensity score matching ,Female ,Neurology (clinical) ,medicine.symptom ,business ,Complication ,Glioblastoma ,030217 neurology & neurosurgery ,Craniotomy ,Follow-Up Studies - Abstract
PURPOSE: Extent of resection remains a paramount prognostic factor for long-term outcomes for glioblastoma. As such, supramaximal resection or anatomic lobectomy have been offered for non-eloquent glioblastoma in an attempt to improve overall survival. Here, we conduct a propensity-matched analysis of patients with non-eloquent glioblastoma who underwent either lobectomy or gross total resection of lesion to investigate the efficacy of supramaximal resection of glioblastoma. METHODS: Patients who underwent initial surgery for gross total resection or lobectomy for non-eloquent glioblastoma at our tertiary care referral center from 2010-2019 were included for this propensity-matched survival analysis. Propensity scores were generated with the following covariates: age, location, preoperative KPS, product of perpendicular maximal tumor diameters, and product of perpendicular FLAIR signal diameters. Inverse probability of treatment weighting (IPTW) with generated propensity scores was used to compare progression-free survival and overall survival. RESULTS: Sixty-nine patients were identified who underwent initial resection of glioblastoma for non-eloquent glioblastoma from 2010-2019 (GTR=37, lobectomy=32). Using IPTW, overall survival (30.7 vs. 14.1 months) and progression-free survival (17.2 vs. 8.1 months were significantly higher in the lobectomy cohort compared to the GTR group (p
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.